# Silo Pharma, Inc.: Form 8-K, filed Jun 3, 2026

- Company: [Silo Pharma, Inc.](/companies/silo.md) (CIK 1514183)
- Form: 8-K
- Filed: 2026-06-03
- Accepted by EDGAR: Jun 3, 2026, 17:00 ET
- Period: 2026-06-01
- Accession: 0001213900-26-064804
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/ea0293111-8k_silo.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/ea0293111-8k_silo.htm

Filed Jun 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-064804. Last ingested by Listed: Nov 6, 2026, 18:16 ET. No prices; not investment advice.